Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin as Treatment of Patients With Cirrhosis and Hepatorenal Syndrome. Effect on Survival and Renal Function. Multicenter, Randomized and Prospective Study

NCT00287664 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT00287664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin as Treatment of Patients With Cirrhosis and Hepatorenal Syndrome. Effect on Survival and Renal Function. Multicenter, Randomized and Prospective Study
Lead sponsor
Hospital Clinic of Barcelona
Phase
Phase 4
Overall status
Suspended
Start date
February 28, 2002
Completion date
September 30, 2006
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatorenal syndrome